Showing results (151-160 of 198) with videos related to

Sort By:
Pageof 20
Scientific Reports|March 18, 2023
Blockchain enabled data security in vehicular networksNaseem Us Sehar, Osman Khalid, Imran Ali Khan, et al.
Journal of Clinical Laboratory Analysis|December 11, 2020
VE1 immunohistochemistry is an adjunct tool for detection of BRAF<sup>V600E</sup> mutation: Validation in thyroid cancer patientsFaiza A Rashid, Sobia Tabassum, Mosin S Khan, et al.
Communications Biology|February 24, 2026
Epigenetic landscape of the H3K27me3 mark in macrophages transformed by Theileria annulataTakaya Sakura, Shahin Tajeri, Zineb Rchiad, et al.
Obstetrics and Gynecology|November 2, 2023
Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Delivery: A Randomized Controlled TrialJessica R Ansari, Alla Yarmosh, Guillermina Michel, et al.
Medical Hypotheses|September 21, 2010
Hydrogen therapy may reduce the risks related to radiation-induced oxidative stress in space flightMichael P Schoenfeld, Rafat R Ansari, June F Zakrajsek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized studyN H Hanna, A B Sandier, P J Loehrer, et al.
Investigational New Drugs|September 20, 2001
Altretamine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group trialR T Zon, J McClean, D Helman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trialP J Loehrer, S Turner, P Kubilis, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 10, 2008
Clinical detection of precataractous lens protein changes using dynamic light scatteringManuel B Datiles, Rafat R Ansari, Kwang I Suh, et al.
American Journal of Clinical Oncology|June 17, 1998
CODE (cisplatin, vincristine, doxorubicin, etoposide) plus granulocyte colony-stimulating factor in advanced non-small-cell lung cancer: a Hoosier Oncology Group phase II trialA Sandler, C Blanke, F Monaco, et al.
Pageof 20